Corvus Pharmaceuticals(US:CRVS) Seeking Alpha·2025-11-09 15:46Core Insights - The article discusses Corvus Pharmaceuticals, Inc. (CRVS) and its stock performance, highlighting a significant rally that occurred nearly a year ago [1]. Group 1: Company Overview - Corvus Pharmaceuticals, Inc. is being revisited after a substantial period, indicating a renewed interest in the company's stock performance [1]. - The company is part of a broader discussion on biotech stocks, which are characterized by high volatility and potential for large returns [1]. Group 2: Analyst Background - Bret Jensen, a market analyst with over 13 years of experience, specializes in identifying high-potential biotech investments [1]. - Jensen leads The Biotech Forum, which offers a model portfolio of 12-20 biotech stocks with high upside potential, along with live discussions and weekly updates [1].